Yahoo India Web Search

Search results

  1. 2 days ago · Luyue Niu, Lu Wang, Ying Ye, Ruilin Zheng, Wenhao Li, Jia-Yue Yang, Chao Liu, Lu Liu, Xiaoxin Zheng, Jing Ren and Jianzhong Zhang Abstract The perovskite quantum dots (PQDs) have emerged as a promising field and dynamic modulation of PQDs could induce reversible color alterations of the PQDs-doped glass.

  2. 1 day ago · The identification of plant disease-resistance genes is essential for understanding the plant immune system and accelerating crop breeding with disease resistance. Therefore, there is a pressing need for a method capable of accurately and comprehensively annotating resistance genes at a genome-wide scale. In this study, we propose Evolutionary Scale Modeling for LRR (ESM-LRR), a novel approach based on the deep protein language model to accurately identify LRR domains which are substantially ...

  3. Sep 1, 2024 · Ying Li Gui-An Wen +4 authors Jianzhong Zhang. Chemistry, Materials Science. Chemical communications. 2022;

  4. Sep 16, 2024 · Funding: This work was supported by National Natural Science Foundation of China (31827801), the Project for software development and expansive application of Chinese Helicobacter pylori antimicrobial resistance dynamic map (29135), the Project for collaborative research on analysis of Helicobacter pylori infection and gut flora changes (29118), and Project for new techniques exploration for bacterial pathogens laboratory detection (32073).

  5. 5 days ago · Despite the reduced pathogenicity of the currently prevalent Omicron variant of SARS-CoV-2, there is still a risk of severe illness and death. Currently, there are no specific biomarkers available to accurately predict the progression and outcomes of Omicron induced COVID-19.

  6. Sep 9, 2024 · Find Jianzhong Zhang's articles, email address, contact information, Twitter and more

  7. Sep 20, 2024 · Stapokibart (CM310) is a humanized IL-4Rα monoclonal antibody currently undergoing phase 3 trials for type 2 inflammatory diseases. In contrast to dupilumab, which bound exclusively to human IL-4Rα, stapokibart demonstrated cross-species reactivity to IL-4Rα from human, cynomolgus monkey, and rat.